Home > Name List By other > [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1, 3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate India

CAS No 97240-79-4 , [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,
3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate Search by region : India

  • Name: [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,
    3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
  • Synonyms: Topina; Tipiramato [Spanish]; Tipiramate [French]; Epitomax;[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,
    3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate; Topamax Sprinkle; Topimax; McN-4853;Topamax; Topomax;
  • CAS Registry Number:
  • Melting Point: 125 ºC
  • Density: 1.336 g/cm3
  • Refractive index: 1.497
  • Water Solubility: DMSO Solubility : ~44 mg/mL
  • Safety Statements: 26-36
  • Hazard Symbols: Xn: Harmful;
  • Molecular Weight: 339.36204
  • InchiKey: KJADKKWYZYXHBB-XBWDGYHZSA-N
  • InChI: InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,
    14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,
    8-,9+,12+/m1/s1
  • Risk Statements: 36/37/38
  • Molecular Formula: C12H21NO8S
  • Molecular Structure:CAS No:97240-79-4 [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,<br />3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate

Related products

Select to

97240-79-4 TOPIRAMATE

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

97240-79-4 topiramate

  • India Maithili Life Sciences [Manufacturers]
  • Tel: +91 9963263336
  • Fax: +91-4040062330
  • Address: Plot#146A, IDA Mallapur, Hyderabad - 500072 null,APIndia
Contact Supplier

97240-79-4 Topiramate

  • India Exim-Pharm International null
  • Tel: +91-(22)-26191948
  • Fax: +91-(22)-26191948
  • Address: 1, Ashish Mahal, 2nd Floor, Ist Road, Golibar Santacruz (E), Mumbai, Maharashtra 400 055, null,nullIndia
Contact Supplier

97240-79-4 TOPIRAMATE

  • India VARDA Biotech (P) Ltd. [Manufacturer]
  • Tel: +91-22-6693 5686 / 2673 0141 / 2673 4258
  • Fax: +91-22-6693 5687
  • Address: 110 & 111, Kartik Complex
    New link Road, Andheri-(W)
    Mumbai-400053, INDIA. null,nullIndia
Contact Supplier

97240-79-4 Topiramate

  • India Steamline Industries Ltd. null
  • Tel: +91-(22)-40999700, 9833720865
  • Fax: +91-(22)-40999777
  • Address: 901/904 Jagdamba Commercial Complex A/2, Near Movitime Theatre, Link Road, Malad (W), Mumbai, Maharashtra 400064, null,nullIndia
Contact Supplier

97240-79-4 topiramate

  • India Orex Pharma Pvt., Ltd [Manufacturers]
  • Tel: 91-22-2536 5317, 2533 3379.
  • Fax: 91-22-2536 9542
  • Address: Pisal House, Nakhwa Compound,Stadium Road, Near CIDCO Bus Stand,Thane (WEST) - 400 601 INDIA. Thane,ThaneIndia
Contact Supplier

97240-79-4 topiramate

  • India Orex Pharma Pvt Ltd [Manufacturer, Distributor/Wholesaler]
  • Tel: 91-22-25333379
  • Fax: +91-22-25369542
  • Address: Pisal house, nakwa compound, stadium rd, Thane Thane,MaharashtraIndia
Contact Supplier

Select to

References of [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,
3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate
Title: Topiramate
CAS Registry Number: 97240-79-4
CAS Name: 2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
Synonyms: 2,3:4,5-di-O-isopropylidene-b-D-fructopyranose sulfamate
Manufacturers' Codes: McN-4853; RWJ-17021-000
Trademarks: Topamax (J & J)
Molecular Formula: C12H21NO8S
Molecular Weight: 339.36
Percent Composition: C 42.47%, H 6.24%, N 4.13%, O 37.72%, S 9.45%
Literature References: Sulfamate substituted monosaccharide; structurally distinct antiepileptic agent. Prepn: B. E. Maryanoff, J. F. Gardocki, US 4513006 (1985 to McNeil); and anticonvulsant activity: B. E. Maryanoff et al., J. Med. Chem. 30, 880 (1987). GC determn in plasma: M. L. Holland et al., J. Chromatogr. 433, 276 (1988). Comparative pharmacokinetics: M. Bialer, Clin. Pharmacokinet. 24, 441 (1993). Series of articles on pharmacology and clinical experience in epilepsy: Epilepsia 38, Suppl. 1, 1-62 (1997). Review of clinical trials in migraine prevention: G. Bussone et al., Int. J. Clin. Pract. 59, 961-968 (2005); of pharmacology and clinical experience: S. D. Silberstein et al., Clin. Ther. 27, 154-165 (2005).
Properties: Crystals from ethyl acetate + hexane, mp 125-126°. [a]D23 -34.0° (c = 0.4 in methanol).
Melting point: mp 125-126°
Optical Rotation: [a]D23 -34.0° (c = 0.4 in methanol)
Therap-Cat: Anticonvulsant; antimigraine.
Keywords: Anticonvulsant; Antimigraine.